Alexion Europe Sas
Manufacturer / marketing-authorisation holder
Alexion Europe Sas — 15 products across 2 markets, 5 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Alexion Europe Sas — 15 productos en 2 mercados, 5 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Alexion Europe Sas —— 共 15 个产品,覆盖 2 个市场、5 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
15 products · 2 markets · 5 brand names
15 productos · 2 mercados · 5 marcas
15 个产品 · 2 个市场 · 5 个品牌名
Products by country
ES
Source: cima.aemps.es
| Brand | Active ingredient(s) | Form |
|---|---|---|
| KANUMA | Sebelipasa Alfa | injection |
| SOLIRIS | 依库珠单抗 | injection |
| STRENSIQ | Asfotasa Alfa | injection |
| STRENSIQ | Asfotasa Alfa | injection |
| STRENSIQ | Asfotasa Alfa | injection |
| STRENSIQ | Asfotasa Alfa | injection |
| Ultomiris | Ravulizumab | injection |
| Ultomiris | Ravulizumab | injection |
| Voydeya | Danicopan | tablet |
| Voydeya | Danicopan | tablet |
EU
Source: www.ema.europa.eu
| Brand | Active ingredient(s) | Form |
|---|---|---|
| KANUMA | Sebelipase Alfa | unknown |
| SOLIRIS | 依库珠单抗 | unknown |
| STRENSIQ | Asfotase Alfa | unknown |
| Ultomiris | Ravulizumab | unknown |
| Voydeya | Danicopan | unknown |